Literature DB >> 8976520

Vitrectomy and systemic fluconazole for treatment of endogenous fungal endophthalmitis.

N J Christmas1, W E Smiddy.   

Abstract

BACKGROUND AND
OBJECTIVE: To investigate the efficacy of pars plana vitrectomy and oral fluconazole without injection of intravitreal antimycotic agents in the treatment of vitritis resulting from Candida endophthalmitis. PATIENTS AND METHODS: Six eyes of five patients with suspected Candida endophthalmitis were treated with pars plana vitrectomy and systemic fluconazole for at least 3 weeks. Patients were observed postoperatively for at least 4 months.
RESULTS: Clinical signs of infection cleared and visual acuity improved postoperatively in all six cases. One recurrent case was attributed to a retained indwelling venous catheter.
CONCLUSIONS: Treatment of advanced endogenous Candida endophthalmitis with vitrectomy and systemic fluconazole offers an effective alternative to management with intravitreal amphotericin B in selected cases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8976520

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers        ISSN: 1082-3069


  6 in total

Review 1.  Fungal and parasitic infections of the eye.

Authors:  S A Klotz; C C Penn; G J Negvesky; S I Butrus
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 2.  Invasive candidiasis in pediatric intensive care units.

Authors:  Sunit Singhi; Akash Deep
Journal:  Indian J Pediatr       Date:  2009-11-12       Impact factor: 1.967

3.  Safety of intravitreal voriconazole: electroretinographic and histopathologic studies.

Authors:  Hua Gao; Mark Pennesi; Kekul Shah; Xiaoxi Qiao; Seenu M Hariprasad; William F Mieler; Samuel M Wu; Eric R Holz
Journal:  Trans Am Ophthalmol Soc       Date:  2003

4.  Can cryotherapy be used as an adjunct in select cases of recalcitrant endophthalmitis? - A case report.

Authors:  Shreyansh Doshi; Avinash Pathengay; Sharat Hegde; Bhavik Panchal
Journal:  Indian J Ophthalmol       Date:  2019-11       Impact factor: 1.848

5.  Liposomal flucytosine capped with gold nanoparticle formulations for improved ocular delivery.

Authors:  Heba F Salem; Sayed M Ahmed; Mahmoud M Omar
Journal:  Drug Des Devel Ther       Date:  2016-01-13       Impact factor: 4.162

6.  Is routine ophthalmoscopy really necessary in candidemic patients?

Authors:  Antonio Vena; Patricia Muñoz; Belen Padilla; Maricela Valerio; Maria Isabel Sanchez; Mireia Puig-Asensio; Jesus Fortun; Mario Fernandez-Ruiz; Paloma Merino; Juan Emilio Losa; Ana Loza; Rosa Ana Rivas; Emilio Bouza
Journal:  PLoS One       Date:  2017-10-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.